Authors
Latest:
BCC Patient Case ImpressionsSherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.
Latest:
SPROUT Trial Highlights Benefits of Apremilast for Pediatric PsoriasisThe trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.
Latest:
An Increase in Skin Cancer Calls for an Increase in Treatment OptionsTo address the increased rates of skin cancer while keeping unique patient needs top of mind, there is a pressing need to increase options for treatment.
Latest:
The Dx and Rx of Congenital Malalignment Syndrome in ChildrenCongenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Latest:
Evan Rieder, MD: Equipping Patients With Tools for Skin AcceptanceFollowing this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.
Latest:
Tailoring Aesthetic Treatments for Patients With Skin of ColorOmer Ibrahim, MD, discusses the nuances of aesthetic procedures for patients with skin of color and the importance of tailored treatments, safety, and improved clinician education.
Latest:
Select Medical Software Based on Your Practice’s Life Cycle StageThough providers probably can use any type of medical software, the financial resources they are able to invest in medical solutions differ significantly based on the type of practice.
Latest:
Nonsurgical Treatments for Advanced BCC ManagementPanelists discuss how emerging nonsurgical options such as hedgehog pathway inhibitors, immune checkpoint inhibitors, and photodynamic therapy are expanding treatment possibilities for patients with advanced basal cell carcinoma (BCC), particularly for those unsuitable for or unresponsive to traditional surgical interventions.
Latest:
Addressing Cutaneous Blisters and Chronic Bullous Disorders With Megan Noe, MD, MPH, MSCEMegan Noe, MD, MPH, MSCE, reviews best practices for treating patients with cutaneous blisters and managing chronic bullous disorders.
Latest:
Q&A: Late-Breaking REMIX-1 and REMIX-2 Data Demonstrated Efficacy of Remibrutinib in Chronic Spontaneous UrticariaAllergist immunologist Giselle Mosnaim, MD, recently spoke with Dermatology Times to discuss late-breaking phase 3 REMIX-1 and REMIX-2 data presented at the American Academy of Allergy, Asthma, and Immunology Annual Meeting.
Latest:
Christophe Piketty, MD, PhD: The Role of Nemolizumab in Addressing Unmet Needs of Patients With AD and PNChristophe Piketty, MD, PHD, provides a deeper look at the promise of nemolizumab in addressing unmet needs faced by patients with atopic dermatitis and prurigo nodularis.
Latest:
In Skin Cancer, Immunotherapy May Lead to Chronic EffectsResearch showed that many patients with skin cancer who had been treated using immunotherapy, such as immune checkpoint inhibition, experienced chronic side effects.
Latest:
Denise Dajles, DEng, MSc, Ushers in a New Era at Cytrellis Biosystems, Looks to Future of Aesthetics IndustryCytrellis' new president and CEO discusses bridging surgery and innovation in aesthetics.
Latest:
Insight from Anant Madabhushi, PhD on AI in Dermatologic CareHis keynote speech at ACMS focused on artificial intelligence for precision medicine and cancer diagnosis.
Latest:
National Eczema Association Expands Visual Guide to Address Skin Tone DisparitiesWendy Smith Begolka, MBS, and Renata Block, MMS, PA-C discuss the NEA's expanded eczema visual guide and upcoming Chicago event to support diverse patient communities.
Latest:
Measuring Atopic Dermatitis Treatment SuccessGina Mangin, MPAS, PA-C, discusses how measuring atopic dermatitis treatment success requires evaluating multiple factors, including reduction in itch intensity, improvement in sleep quality, decreased flare frequency, enhanced quality of life, and visible skin healing through standardized assessment tools and patient-reported outcomes.
Latest:
Vitiligo Case Report: A 9-Year Old Patient With White Macules, Halo NevusJordan Bui and Bernard A. Cohen, MD, review a case of a young patient with vitiligo.
Latest:
Phase 3 Ruxolitinib Study Shows Higher Rates of Adolescent RepigmentationDavid Rosmarin, MD, shared his insights on the study in a Q&A with Dermatology Times.
Latest:
Turn Therapeutics' Atopic Dermatitis Candidate Achieves 57% Reduction in Disease Severity in 7 DaysBradley Burnam discusses results from an in-vivo model of atopic dermatitis.
Latest:
Test Your Knowledge: OncodermatologyEarlier this summer, Meghan Heberton, MD, emphasized the importance and growth of the subspecialty.
Latest:
Dupilumab Shows No APO Risk During PregnancyCompared to untreated patients, dupilumab-treated women showed no increased risk for spontaneous abortion, gestational diabetes, or hypertensive disorders.
Latest:
Rad Quotes From RAD 2023Experts in the field share why they enjoyed the 5th Annual Revolutionizing Atopic Dermatitis Conference and why it is unique.
